ImportantYou have 60 days to appeal a denial. Don't miss your deadline.Check your appeal timeline →
How to ApplyAfter a DenialState GuidesAbout UsContact Us

Does SSDI Use Pre- or Post-Bronchodilator FEV1 Values When Evaluating Lung Conditions?

When the Social Security Administration reviews a disability claim involving a breathing condition, the specific lung function numbers in your medical records carry significant weight. One of the most common questions claimants and their doctors have is whether SSA looks at pre-bronchodilator or post-bronchodilator FEV1 values — and the answer has real consequences for how a respiratory claim is evaluated.

What FEV1 Measures and Why It Matters for SSDI

FEV1 stands for Forced Expiratory Volume in one second — the amount of air a person can forcibly exhale in a single second during a spirometry test. It's one of the primary measurements used to gauge airflow obstruction in conditions like COPD, asthma, chronic bronchitis, and emphysema.

A bronchodilator is a medication (such as albuterol) that opens the airways. Spirometry is often performed twice: once before the medication is administered (pre-bronchodilator) and once after (post-bronchodilator). The gap between these two readings can tell clinicians — and SSA — how much of the obstruction is reversible.

SSA's Official Position: Post-Bronchodilator Values Apply 🫁

Under SSA's Listing of Impairments (the "Blue Book"), specifically Listing 3.02 for chronic respiratory disorders, SSA evaluates spirometry results using post-bronchodilator values when a bronchodilator is medically appropriate and has been administered.

The relevant language in SSA's regulations states that FEV1 values should reflect the measurement obtained after bronchodilator use — provided the treating source administered a bronchodilator during the test and it was clinically appropriate to do so.

This is a meaningful distinction. Post-bronchodilator FEV1 values are typically higher than pre-bronchodilator values. Because Listing 3.02 requires FEV1 to fall at or below a specific threshold (which varies by height), using the post-bronchodilator reading means SSA is measuring lung function at its best — making it harder to meet the listing threshold on spirometry alone.

The Listing 3.02 Thresholds at a Glance

SSA's FEV1 thresholds under Listing 3.02 are height-based. The shorter a person is, the lower the absolute FEV1 threshold they must fall under to meet the listing. For example, a person who is 60 inches tall faces a different cutoff than someone who is 72 inches tall.

Height (without shoes)FEV1 equal to or less than
60 inches or under1.05 L
61–63 inches1.15 L
64–65 inches1.25 L
66–67 inches1.35 L
68–69 inches1.45 L
70–71 inches1.55 L
72 inches or over1.65 L

These figures are drawn from SSA's published Listing 3.02 criteria. Always verify against current SSA publications, as listings can be updated.

When Bronchodilators Aren't Used — or Aren't Appropriate

Not every spirometry test includes bronchodilator administration. If a bronchodilator was not used during the test — whether due to clinical contraindication, the patient's condition, or testing protocol — SSA will use the available pre-bronchodilator values.

This matters because pre-bronchodilator FEV1 values are typically lower and may be more likely to fall within listing-level thresholds. The quality and completeness of the spirometry record can therefore affect how your claim is assessed at the Disability Determination Services (DDS) level during the initial review and reconsideration stages.

SSA also considers whether spirometry results meet acceptable technical standards — including that the test was performed correctly, with sufficient effort and reproducibility. A test flagged as technically inadequate may not be used to meet a listing, regardless of the numbers it shows.

Meeting the Listing vs. Equaling It vs. Getting Approved Another Way

Even if a claimant's FEV1 values don't fall below Listing 3.02 thresholds, a respiratory disability claim isn't automatically over. SSA evaluates three pathways: ⚖️

  1. Meeting the listing — Spirometry (or other criteria like DLCO or oxygen saturation) falls within the defined thresholds.
  2. Medically equaling the listing — The combination of impairments is judged equivalent in severity, even without meeting the exact criteria.
  3. Residual Functional Capacity (RFC) assessment — SSA evaluates what work-related activities you can still perform, factoring in breathing limitations alongside other physical and mental impairments.

Many approved respiratory claims involve claimants who didn't meet the listing numerically but whose RFC — accounting for exertional limits, need for frequent rest, oxygen use, or combined conditions — showed they couldn't sustain full-time work.

Variables That Shape How These Numbers Play Out

How FEV1 results affect a specific claim depends on several factors that vary by individual:

  • Whether bronchodilators were administered during spirometry testing
  • The claimant's height, which determines the applicable FEV1 threshold
  • Other respiratory measurements in the record (FVC, DLCO, oxygen saturation)
  • Frequency and severity of exacerbations documented in treatment notes
  • Comorbid conditions — heart disease, obesity, or anxiety can compound respiratory limitations
  • Age and work history, which affect the RFC grid rules and what jobs SSA considers available
  • Whether the claim is at initial review, reconsideration, or ALJ hearing, since medical evidence development may differ at each stage

A claimant whose post-bronchodilator FEV1 sits just above a listing threshold but who also has documented hypoxemia, cor pulmonale, or frequent hospitalizations is in a meaningfully different position than someone with similar FEV1 numbers and a cleaner medical history. 🔍

The FEV1 value in your records is one data point inside a larger evidentiary picture — and how SSA weighs that picture depends entirely on what's in your specific file.